The human gastrointestinal tract-specific transcriptome and proteome as defined by RNA sequencing and antibody-based profiling

Journal of Gastroenterology

Volumn 50, Issue 1, 2015, Pages 46-57

  Gremel, Gabriela ^a,b   Wanders, Alkwin ^a   Cedernaes, Jonathan ^b   Fagerberg, Linn ^c   Hallström, Björn ^c   Edlund, Karolina ^a,b   Sjöstedt, Evelina ^a,b   Uhlén, Mathias ^c   Pontén, Fredrik ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

Gastrointestinal tract; Immunohistochemistry; RNA expression

Indexed keywords

MESSENGER RNA; PROTEOME; TRANSCRIPTOME;

GASTROINTESTINAL TRACT; GENE EXPRESSION PROFILING; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN; METABOLISM; PROCEDURES; PROTEOMICS; SEQUENCE ANALYSIS;

GASTROINTESTINAL TRACT; GENE EXPRESSION PROFILING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PROTEOME; PROTEOMICS; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME;

EID: 84924299302     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-014-0958-7     Document Type: Article

References (51)

1. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011;12:453–66.
2. Holzer P, Reichmann F, Farzi A. Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. Neuropeptides. 2012;46:261–74.
3. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology. 2009;136:65–80.
4. O’Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006;7:688–93.
5. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9:313–23.
6. Molodecky NA, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54 (e42 quiz e30).
7. Ferlay J, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.
8. Dalerba P, et al. Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat Biotechnol. 2011;29:1120–7.
9. Comelli EM, et al. Biomarkers of human gastrointestinal tract regions. Mamm Genome. 2009;20:516–27.
10. Fagerberg L, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2014;13(2):397–406.
11. Ponten F, et al. The Human Protein Atlas as a proteomic resource for biomarker discovery. J Intern Med. 2011;270:428–46.
12. Kircher M, Sawyer S, Meyer M. Double indexing overcomes inaccuracies in multiplex sequencing on the Illumina platform. Nucleic Acids Res. 2012;40:e3.
13. Ponten F, Jirstrom K, Uhlen M. The Human Protein Atlas–a tool for pathology. J Pathol. 2008;216:387–93.
14. Kampf C, et al. Antibody-based tissue profiling as a tool in clinical proteomics. Clin Proteomics. 2004;1:285–300.
15. Trapnell C, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010;28:511–5.
16. Hebenstreit D, et al. RNA sequencing reveals two major classes of gene expression levels in metazoan cells. Mol Syst Biol. 2011;7:497.
17. Kageyama T. Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development. Cell Mol Life Sci. 2002;59:288–306.
18. van Driel IR, Callaghan JM. Proton and potassium transport by H+/K(+)-ATPases. Clin Exp Pharmacol Physiol. 1995;22:952–60.
19. Alpers DH, Russell-Jones G. Gastric intrinsic factor: the gastric and small intestinal stages of cobalamin absorption. a personal journey. Biochimie. 2013;95:989–94.
20. Ma K, Mallidis C, Bhasin S. The role of Y chromosome deletions in male infertility. Euro J Endocrinol. 2000;142:418–30.
21. Uhlen M, et al. Towards a knowledge-based Human Protein Atlas. Nat Biotechnol. 2010;28:1248–50.
22. Fujimoto K, Polonsky KS. Pdx1 and other factors that regulate pancreatic beta-cell survival. Diabetes Obes Metab. 2009;11(Suppl 4):30–7.
23. Guz Y, et al. Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development. 1995;121:11–8.
24. Chen C, Sibley E. Expression profiling identifies novel gene targets and functions for Pdx1 in the duodenum of mature mice. Am J Physiol Gastrointest Liver Physiol. 2012;302:G407–19.
25. Holland AM, et al. The Parahox gene Pdx1 is required to maintain positional identity in the adult foregut. Int J Dev Biol. 2013;57:391–8.
26. Ose R, et al. PCDH24-induced contact inhibition involves downregulation of beta-catenin signaling. Mol Oncol. 2009;3:54–66.
27. Okazaki N, et al. Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation. Carcinogenesis. 2002;23:1139–48.
28. Mashima H, et al. INSL5 may be a unique marker of colorectal endocrine cells and neuroendocrine tumors. Biochem Biophys Res Commun. 2013;432:586–92.
29. Thanasupawat T, et al. INSL5 is a novel marker for human enteroendocrine cells of the large intestine and neuroendocrine tumours. Oncol Rep. 2013;29:149–54.
30. Conklin D, et al. Identification of INSL5, a new member of the insulin superfamily. Genomics. 1999;60:50–6.
31. Liu C, et al. INSL5 is a high affinity specific agonist for GPCR142 (GPR100). J Biol Chem. 2005;280:292–300.
32. Pemberton AD, et al. Innate BALB/c enteric epithelial responses to Trichinella spiralis: inducible expression of a novel goblet cell lectin, intelectin-2, and its natural deletion in C57BL/10 mice. J Immunology. 2004;173:1894–901.
33. Wrackmeyer U, et al. Intelectin: a novel lipid raft-associated protein in the enterocyte brush border. Biochemistry. 2006;45:9188–97.
34. Elinav E, et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell. 2011;145:745–57.
35. Hu B, et al. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proc Natl Acad Sci. 2013;110:9862–7.
36. Sun Y, et al. Stress-induced corticotropin-releasing hormone-mediated NLRP6 inflammasome inhibition and transmissible enteritis in mice. Gastroenterology. 2013;144(1478–87):e8.
37. Agius L. Glucokinase and molecular aspects of liver glycogen metabolism. Biochem J. 2008;414:1–18.
38. Gosmain Y, et al. Glucagon gene expression in the endocrine pancreas: the role of the transcription factor Pax6 in alpha-cell differentiation, glucagon biosynthesis and secretion. Diabetes Obes Metab. 2011;13(Suppl 1):31–8.
39. Bu H, et al. Anterior gradient 2 and 3–two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells. FEBS J. 2013;280:1249–66.
40. Diggle CP, et al. Ketohexokinase: expression and localization of the principal fructose-metabolizing enzyme. J Histochem Cytochem. 2009;57:763–74.
41. Shi H, et al. Overexpression of aminoacylase 1 is associated with colorectal cancer progression. Hum Pathol. 2013;44:1089–97.
42. Hsiao LL, et al. A compendium of gene expression in normal human tissues. Physiol Genomics. 2001;7:97–104.
43. Shyamsundar R, et al. A DNA microarray survey of gene expression in normal human tissues. Genome Biol. 2005;6:R22.
44. Lukk M, et al. A global map of human gene expression. Nat Biotechnol. 2010;28:322–4.
45. Hwang PI, et al. Tissue-specific gene expression templates for accurate molecular characterization of the normal physiological states of multiple human tissues with implication in development and cancer studies. BMC Genomics. 2011;12:439.
46. Magnusson K, et al. SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas. Am J Surg Pathol. 2011;35:937–48.
47. Eberhard J, et al. A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer. Br J Cancer. 2012;106:931–8.
48. Ehlen A, et al. Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer. J Transl Med. 2010;8:78.
49. Jonsson L, et al. Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmo Diet and Cancer Study. J Transl Med. 2011;9:114.
50. Boman K, et al. Decreased expression of RBM3 correlates with tumour progression and poor prognosis in urinary bladder cancer. Histopathology. 2012;61:147.
51. Pacha J, Sumova A. Circadian regulation of epithelial functions in the intestine. Acta Physiol (Oxf). 2013;208:11–24.